Sagace Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$458K Sell
1,875
-547
-23% -$127K 0.31% 48
2025
Q4
$501K Sell
2,422
-34
-1% -$6.72K 0.34% 43
2025
Q3
$455K Sell
2,456
-636
-21% -$109K 0.31% 45
2025
Q2
$472K Sell
3,092
-549
-15% -$84.4K 0.35% 44
2025
Q1
$604K Buy
3,641
+21
+0.6% +$3.29K 0.46% 41
2024
Q4
$524K Sell
3,620
-254
-7% -$39.4K 0.39% 48
2024
Q3
$626K Buy
+3,874
New +$617K 0.48% 41

Other funds holding JNJ

Sagace Wealth Management's JNJ Position: Q1 2026 in Review

Sagace Wealth Management reduced its Johnson & Johnson (JNJ) stake by 23% in Q1 2026, selling an estimated $127K and leaving 1,875 shares worth $458K. The position accounts for 0.31% of the portfolio, ranked #48.

Sagace Wealth Management first reported a position in JNJ in Q3 2024 and has held it in 7 quarters since. The position peaked at $626K in Q3 2024. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Sagace Wealth Management held 1,875 shares of Johnson & Johnson worth $458K as of Q1 2026.
  • Sagace Wealth Management sold 547 Johnson & Johnson shares in Q1 2026, an estimated $127K.
  • Johnson & Johnson made up 0.31% of Sagace Wealth Management's portfolio in Q1 2026, its #48 holding.
  • Sagace Wealth Management first reported a position in Johnson & Johnson in Q3 2024 and has held it in 7 quarters since.
  • Sagace Wealth Management's Johnson & Johnson position peaked at $626K in Q3 2024.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Sagace Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.